KRAS and melanoma: In horses, BRAF, NRAS, KRAS, and KIT mutations have been observed in 7.1% (2/28), 8.3% (5/60), 0/62 (0%), and 3.6% (1/28) of melanoma samples (summary see Supplement Table S1) [4,5,6,7].